A carregar...
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
Long-acting injectable antipsychotics (LAIs) were developed to make treatment easier, improve adherence, and/or signal the clinician when nonadherence occurs. Second-generation antipsychotic LAIs (SGA-LAIs) combine the advantages of SGA with a long-acting formulation. The purpose of this review is t...
Na minha lista:
| Publicado no: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4844443/ https://ncbi.nlm.nih.gov/pubmed/27143893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S88632 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|